{"title":"Prevalence of Anxiety in Smoking Cessation: A Worldwide Systematic Review and Meta-analysis","authors":"S. Amiri","doi":"10.1097/ADT.0000000000000263","DOIUrl":null,"url":null,"abstract":"Objectives: Smoking cessation can have a significant impact on mental health, so this study aimed to investigate the prevalence of anxiety after smoking cessation by a worldwide systematic review and meta-analysis. Methods: PubMed and Scopus were selected for the study and these were systematically searched until October 2020 based on a syntax of keywords. This search in these 2 databases is limited to English. The event and sample size were used to assess the prevalence of anxiety. The prevalence of anxiety was also assessed based on anxiety disorders and continents. The odds ratio (OR) was used to compare the odd of anxiety in smoking cessation versus nonsmokers and smokers as reference groups based on a random-effects method. Heterogeneity and publication bias were assessed. Results: The prevalence of anxiety after smoking cessation is 19% with a confidence interval (CI) of 14%-24%. Among anxiety disorders, it was the highest prevalence for social anxiety with 29% prevalence. The prevalence of anxiety after smoking cessation in America is 15% and in Europe is 29%. Smoking cessation has a higher odd of anxiety than nonsmokers (OR=1.20; CI: 1.12-1.29). Smoking cessation has a lower odd of anxiety than smokers (OR=0.77; CI: 0.66-0.89). Discussion: Since smoking cessation is a factor that reduces anxiety, so in studies in this area as well as therapeutic interventions, it is necessary to consider this issue.","PeriodicalId":44600,"journal":{"name":"Addictive Disorders & Their Treatment","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2021-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addictive Disorders & Their Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ADT.0000000000000263","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1
Abstract
Objectives: Smoking cessation can have a significant impact on mental health, so this study aimed to investigate the prevalence of anxiety after smoking cessation by a worldwide systematic review and meta-analysis. Methods: PubMed and Scopus were selected for the study and these were systematically searched until October 2020 based on a syntax of keywords. This search in these 2 databases is limited to English. The event and sample size were used to assess the prevalence of anxiety. The prevalence of anxiety was also assessed based on anxiety disorders and continents. The odds ratio (OR) was used to compare the odd of anxiety in smoking cessation versus nonsmokers and smokers as reference groups based on a random-effects method. Heterogeneity and publication bias were assessed. Results: The prevalence of anxiety after smoking cessation is 19% with a confidence interval (CI) of 14%-24%. Among anxiety disorders, it was the highest prevalence for social anxiety with 29% prevalence. The prevalence of anxiety after smoking cessation in America is 15% and in Europe is 29%. Smoking cessation has a higher odd of anxiety than nonsmokers (OR=1.20; CI: 1.12-1.29). Smoking cessation has a lower odd of anxiety than smokers (OR=0.77; CI: 0.66-0.89). Discussion: Since smoking cessation is a factor that reduces anxiety, so in studies in this area as well as therapeutic interventions, it is necessary to consider this issue.
期刊介绍:
Addictive Disorders & Their Treatment is a quarterly international journal devoted to practical clinical research and treatment issues related to the misuses of alcohol and licit and illicit drugs and the study and treatment of addictive disorders and their behaviors. The journal publishes broad-spectrum, patient-oriented coverage of all aspects of addiction, directed toward an audience of psychiatrists, clinical psychologists, psychopharmacologists, and primary care practitioners. Original articles help clinicians make more educated, effective decisions regarding optimal patient management and care. In-depth reviews examine current understanding, diagnosis, and treatment of addiction disorders.